返回 Agenda
Collaborative Frameworks and Public Private Partnerships as Drivers of Innovation
Session Chair(s)
Corinne de Vries, PHD, MA, MSC
EMA liaison official to the US FDA
European Medicines Agency, Netherlands
A condensed overview of the current state of play when it comes to PPP s from an EU perspective and their key role in bringing together the latest research and cutting-edge technology to boost innovation and entrepreneurship in the pharmaceutical sector, to meet the challenges faced by patients and society as a whole.
Speaker(s)
Accelerating Innovation through Public Private Partnerships: IMI as an Example
Pierre Meulien, PHD
Innovative Medicines Initiative (IMI), Belgium
Executive Director
Advancing Innovation with Novel Methodologies - C-Path’s PPP Approach to Achieving Regulatory Acceptance
Martha Ann Brumfield, PHD
Critical Path Institute, United States
President and Chief Executive Officer
The IMI SAFE-T Consortium: Engaging with Regulators to Enhance Success and Opportunities of Public Private Partnerships
Gerd Kullak-Ublick
Novartis, Switzerland
Global Head, Mechanistic Safety, Chief Medical Office and Patient Safety